Cargando…

Skp2 and Skp2B team up against Rb and p53

The Skp2 locus encodes two proteins, Skp2 and Skp2B. The role of Skp2 in the ubiquitin-dependent degradation of key regulators of the retinoblastoma protein pathway has been well established. More recent work from the McCormick's group suggested that Skp2 has an ubiquitin-independent function i...

Descripción completa

Detalles Bibliográficos
Autor principal: Germain, Doris
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035582/
https://www.ncbi.nlm.nih.gov/pubmed/21255415
http://dx.doi.org/10.1186/1747-1028-6-1
_version_ 1782197788763750400
author Germain, Doris
author_facet Germain, Doris
author_sort Germain, Doris
collection PubMed
description The Skp2 locus encodes two proteins, Skp2 and Skp2B. The role of Skp2 in the ubiquitin-dependent degradation of key regulators of the retinoblastoma protein pathway has been well established. More recent work from the McCormick's group suggested that Skp2 has an ubiquitin-independent function in the regulation of the p53 pathway. Adding to this observation, we reported that Skp2B also regulates the activity of p53 by degrading a distinct substrate, prohibitin. Since prohibitin has been implicated in the regulation of the Rb pathway, collectively, these observations suggest that Skp2 and Skp2B team up against p53 and Rb.
format Text
id pubmed-3035582
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30355822011-02-09 Skp2 and Skp2B team up against Rb and p53 Germain, Doris Cell Div Commentary The Skp2 locus encodes two proteins, Skp2 and Skp2B. The role of Skp2 in the ubiquitin-dependent degradation of key regulators of the retinoblastoma protein pathway has been well established. More recent work from the McCormick's group suggested that Skp2 has an ubiquitin-independent function in the regulation of the p53 pathway. Adding to this observation, we reported that Skp2B also regulates the activity of p53 by degrading a distinct substrate, prohibitin. Since prohibitin has been implicated in the regulation of the Rb pathway, collectively, these observations suggest that Skp2 and Skp2B team up against p53 and Rb. BioMed Central 2011-01-21 /pmc/articles/PMC3035582/ /pubmed/21255415 http://dx.doi.org/10.1186/1747-1028-6-1 Text en Copyright ©2011 Germain; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Germain, Doris
Skp2 and Skp2B team up against Rb and p53
title Skp2 and Skp2B team up against Rb and p53
title_full Skp2 and Skp2B team up against Rb and p53
title_fullStr Skp2 and Skp2B team up against Rb and p53
title_full_unstemmed Skp2 and Skp2B team up against Rb and p53
title_short Skp2 and Skp2B team up against Rb and p53
title_sort skp2 and skp2b team up against rb and p53
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035582/
https://www.ncbi.nlm.nih.gov/pubmed/21255415
http://dx.doi.org/10.1186/1747-1028-6-1
work_keys_str_mv AT germaindoris skp2andskp2bteamupagainstrbandp53